Neoleukin Therapeutics Inc Shares Fall 2.1% Below Previous 52-Week Low - Market Mover
The shares fell 2.1% lower than its previous 52-week low of $3.81, with trading volume higher than its 30 day average
Jan 13, 2022 by Kwhen Finance Editors
Neoleukin Therapeutics Inc (NLTX) shares closed 2.1% lower than its previous 52 week low, giving the company a market cap of $163M. The stock is currently down 19.9% year-to-date, down 72.4% over the past 12 months, and down 77.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%.
Trading Activity
- Trading volume this week was 46.6% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Neoleukin Therapeutics Inc | -3.4 | -19.9 | -72.4 | -74.0 | 1.8 |
| Dow Jones Industrial Average | 0.1 | -0.2 | 18.9 | -1.6 | 23.8 |
| S&P 500 Index | 0.3 | -1.1 | 25.7 | -1.7 | 29.8 |
| Health Care | -0.3 | -3.5 | 14.4 | -4.5 | 22.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -3395.4%
- The company's stock price performance over the past 12 months lags the peer average by 152.2%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Neoleukin Therapeutics Inc | NLTX | 0 | -19.9 | -72.4 | -74.0 | 1.8 |
| Peer Avg | N/A | 0 | 0.6 | -28.7 | -31.6 | 29.3 |
| ORIC Pharmaceuticals Inc | ORIC | 0 | -1.4 | -54.4 | -63.0 | 29.4 |
| Otonomy Inc | OTIC | 0 | 3.8 | -60.4 | -63.3 | 87.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: